H.R. 1107

119th Congress

In Committee

Protecting Veteran Access to Telemedicine Services Act of 2025

Sponsored byRepublican:Rep. Womack, Steve [R-AR-3]AR· Introduced 6 février 2025

28

Cosponsors

19

Actions

0

Amendments

2

Committees

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

16 septembre 2025·10 months ago

Summary

Introduced in House · Updated 1 mai 2025

Protecting Veteran Access to Telemedicine Services Act of 2025

This bill permanently authorizes certain Department of Veterans Affairs (VA) health care professionals to use telemedicine to deliver, distribute, or dispense controlled substances that are prescription drugs to patients who are eligible for VA health care, regardless of whether the health care professional has conducted an in-person medical examination. The health care professional must be (1) authorized to prescribe the basic class of such controlled substance under an active, current, full, and unrestricted license or certification; (2) acting in the usual course of professional practice; and (3) delivering, distributing, or dispensing the substance for a legitimate medical purpose.

Timeline

19 actions

  1. Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

    16 septembre 2025 · IntroReferral

  2. Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4279-4280: 1)

    15 septembre 2025 · Floor

  3. Considered under suspension of the rules. (consideration: CR H4279)

    15 septembre 2025 · Floor

  4. Mr. Bost moved to suspend the rules and pass the bill, as amended.

    15 septembre 2025 · Floor

  5. DEBATE - The House proceeded with forty minutes of debate on H.R. 1107.

    15 septembre 2025 · Floor

  6. The title of the measure was amended. Agreed to without objection.

    15 septembre 2025 · Floor

  7. Motion to reconsider laid on the table Agreed to without objection.

    15 septembre 2025 · Floor

  8. On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4279)

    15 septembre 2025 · Floor

  9. Placed on the Union Calendar, Calendar No. 179.

    29 juillet 2025 · Calendars

  10. Reported by the Committee on Veterans' Affairs. H. Rept. 119-221.

    29 juillet 2025 · Committee

  11. Reported by the Committee on Veterans' Affairs. H. Rept. 119-221.

    29 juillet 2025 · Committee

  12. Committee Consideration and Mark-up Session Held

    6 mai 2025 · Committee

  13. Forwarded by Subcommittee to Full Committee by Voice Vote.

    25 mars 2025 · Committee

  14. Subcommittee Consideration and Mark-up Session Held

    25 mars 2025 · Committee

  15. Subcommittee Hearings Held

    12 mars 2025 · Committee

  16. Referred to the Subcommittee on Health.

    11 mars 2025 · Committee

  17. Referred to the House Committee on Veterans' Affairs.

    6 février 2025 · IntroReferral

  18. Introduced in House

    6 février 2025 · IntroReferral

  19. Introduced in House

    6 février 2025 · IntroReferral

Sponsorship

28 cosponsors

Sponsor

Republican:Rep. Womack, Steve [R-AR-3]AR

Cosponsors

  • Democrat1554%
  • Republican1346%

Classification

Policy area

Armed Forces and National Security

Legislative subjects

Health care coverage and accessHealth personnelHealth technology, devices, suppliesPrescription drugsVeterans' medical care

Committees

2

  • Veterans' Affairs Committee

    House · Standing

    • Referred To6 Feb 2025
    • Markup By6 May 2025
    • Reported By29 Jul 2025
    • Health Subcommittee

      • Referred to11 Mar 2025
      • Hearings By (subcommittee)12 Mar 2025
      • Markup by25 Mar 2025
      • Reported by25 Mar 2025
  • Veterans' Affairs Committee

    Senate · Standing

    • Referred To16 Sept 2025

Cosponsor momentum

Cumulative over time

Cosponsors grew from 9 on 6 février 2025 to 28 on 22 juillet 2025.

Pelosi Tracker
© 2026 - Tous droits réservés. Propulsé par Vantara Labs
Ce site web est une plateforme indépendante et tierce. Il n'est pas affilié à, approuvé par ou associé de quelque manière que ce soit à Nancy Pelosi, son bureau ou ses représentants. Toute utilisation de son nom est uniquement à des fins de discussion d'informations publiques disponibles.Les informations fournies sur ce site web sont uniquement à des fins informatives et éducatives et ne sont pas destinées à servir de conseils financiers ou d'investissement, ni ne doivent être interprétées comme tels. Les données présentées ici proviennent de déclarations et dossiers publics. Bien que nous nous efforcions d'assurer l'exactitude, l'actualité et l'exhaustivité, nous ne garantissons pas que toutes les informations sont exemptes d'erreurs ou à jour.Le support est disponible en anglais. Certaines traductions sont automatiques.